前立腺肥大症(BPH)の世界市場:市場規模・現状・予測(2019-2025)

【英語タイトル】Global Benign Prostatic Hyperplasia Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料(QYR9051213)・商品コード:QYR9051213
・発行会社(調査会社):QYResearch
・発行日:2019年8月7日(※2024年版があります。お問い合わせください)
・ページ数:94
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当資料は、前立腺肥大症(BPH)のグローバル市場について調査・分析したレポートで、種類別(薬物療法、透析、その他)、用途別(病院、診療所)、主要地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米)の市場規模、市場予測、関連企業情報などが含まれています。

・前立腺肥大症(BPH)の世界市場規模
・主要企業別市場シェア
・前立腺肥大症(BPH)の世界市場規模:種類別(薬物療法、透析、その他)
・前立腺肥大症(BPH)の世界市場規模:用途別(病院、診療所)
・前立腺肥大症(BPH)のアメリカ市場規模(種類別、用途別)
・前立腺肥大症(BPH)のヨーロッパ市場規模(種類別、用途別)
・前立腺肥大症(BPH)の中国市場規模(種類別、用途別)
・前立腺肥大症(BPH)の日本市場規模(種類別、用途別)
・前立腺肥大症(BPH)の東南アジア市場規模(種類別、用途別)
・前立腺肥大症(BPH)のインド市場規模(種類別、用途別)
・前立腺肥大症(BPH)の中南米市場規模(種類別、用途別)
・主要企業別分析(企業概要、製品動向、販売量など)
・前立腺肥大症(BPH)の世界市場予測(2019年-2025年)
・前立腺肥大症(BPH)の地域別市場予測(2019年-2025年)
...
【レポートの概要】

Benign prostatic hyperplasia (BPH) also known as benign prostatic hypertrophy is characterized by the unusual propagation of the prostatic cells, which causes difficulties like urinary retention and infections of the urinary tract. It is most common among the aging men population, primarily driving this market. On the basis of geographical analysis, the North American region is expected to retain its dominance in this market owing to better healthcare infrastructure, high healthcare expenditure on urological disorders, increased awareness in the society increasing the outpatients center and hospitals visits.In 2018, the global Benign Prostatic Hyperplasia market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Benign Prostatic Hyperplasia status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Benign Prostatic Hyperplasia development in United States, Europe and China.

The key players covered in this study
Abbott
Allergan
Astellas Pharma
Boehringer Ingelheim Pharma
Eli Lilly and Company
GlaxoSmithKline
Merck
Pfizer
Sanofi

Market segment by Type, the product can be split into
Drug Therapy
Dialysis
Other

Market segment by Application, split into
Hospitals
Clinics

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Benign Prostatic Hyperplasia status, future forecast, growth opportunity, key market and key players.
To present the Benign Prostatic Hyperplasia development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Benign Prostatic Hyperplasia are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Benign Prostatic Hyperplasia Market Size Growth Rate by Type (2014-2025)
1.4.2 Drug Therapy
1.4.3 Dialysis
1.4.4 Other
1.5 Market by Application
1.5.1 Global Benign Prostatic Hyperplasia Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Benign Prostatic Hyperplasia Market Size
2.2 Benign Prostatic Hyperplasia Growth Trends by Regions
2.2.1 Benign Prostatic Hyperplasia Market Size by Regions (2014-2025)
2.2.2 Benign Prostatic Hyperplasia Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Benign Prostatic Hyperplasia Market Size by Manufacturers
3.1.1 Global Benign Prostatic Hyperplasia Revenue by Manufacturers (2014-2019)
3.1.2 Global Benign Prostatic Hyperplasia Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Benign Prostatic Hyperplasia Market Concentration Ratio (CR5 and HHI)
3.2 Benign Prostatic Hyperplasia Key Players Head office and Area Served
3.3 Key Players Benign Prostatic Hyperplasia Product/Solution/Service
3.4 Date of Enter into Benign Prostatic Hyperplasia Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Benign Prostatic Hyperplasia Market Size by Type (2014-2019)
4.2 Global Benign Prostatic Hyperplasia Market Size by Application (2014-2019)

5 United States
5.1 United States Benign Prostatic Hyperplasia Market Size (2014-2019)
5.2 Benign Prostatic Hyperplasia Key Players in United States
5.3 United States Benign Prostatic Hyperplasia Market Size by Type
5.4 United States Benign Prostatic Hyperplasia Market Size by Application

6 Europe
6.1 Europe Benign Prostatic Hyperplasia Market Size (2014-2019)
6.2 Benign Prostatic Hyperplasia Key Players in Europe
6.3 Europe Benign Prostatic Hyperplasia Market Size by Type
6.4 Europe Benign Prostatic Hyperplasia Market Size by Application

7 China
7.1 China Benign Prostatic Hyperplasia Market Size (2014-2019)
7.2 Benign Prostatic Hyperplasia Key Players in China
7.3 China Benign Prostatic Hyperplasia Market Size by Type
7.4 China Benign Prostatic Hyperplasia Market Size by Application

8 Japan
8.1 Japan Benign Prostatic Hyperplasia Market Size (2014-2019)
8.2 Benign Prostatic Hyperplasia Key Players in Japan
8.3 Japan Benign Prostatic Hyperplasia Market Size by Type
8.4 Japan Benign Prostatic Hyperplasia Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Benign Prostatic Hyperplasia Market Size (2014-2019)
9.2 Benign Prostatic Hyperplasia Key Players in Southeast Asia
9.3 Southeast Asia Benign Prostatic Hyperplasia Market Size by Type
9.4 Southeast Asia Benign Prostatic Hyperplasia Market Size by Application

10 India
10.1 India Benign Prostatic Hyperplasia Market Size (2014-2019)
10.2 Benign Prostatic Hyperplasia Key Players in India
10.3 India Benign Prostatic Hyperplasia Market Size by Type
10.4 India Benign Prostatic Hyperplasia Market Size by Application

11 Central & South America
11.1 Central & South America Benign Prostatic Hyperplasia Market Size (2014-2019)
11.2 Benign Prostatic Hyperplasia Key Players in Central & South America
11.3 Central & South America Benign Prostatic Hyperplasia Market Size by Type
11.4 Central & South America Benign Prostatic Hyperplasia Market Size by Application

12 International Players Profiles
12.1 Abbott
12.1.1 Abbott Company Details
12.1.2 Company Description and Business Overview
12.1.3 Benign Prostatic Hyperplasia Introduction
12.1.4 Abbott Revenue in Benign Prostatic Hyperplasia Business (2014-2019)
12.1.5 Abbott Recent Development
12.2 Allergan
12.2.1 Allergan Company Details
12.2.2 Company Description and Business Overview
12.2.3 Benign Prostatic Hyperplasia Introduction
12.2.4 Allergan Revenue in Benign Prostatic Hyperplasia Business (2014-2019)
12.2.5 Allergan Recent Development
12.3 Astellas Pharma
12.3.1 Astellas Pharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Benign Prostatic Hyperplasia Introduction
12.3.4 Astellas Pharma Revenue in Benign Prostatic Hyperplasia Business (2014-2019)
12.3.5 Astellas Pharma Recent Development
12.4 Boehringer Ingelheim Pharma
12.4.1 Boehringer Ingelheim Pharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Benign Prostatic Hyperplasia Introduction
12.4.4 Boehringer Ingelheim Pharma Revenue in Benign Prostatic Hyperplasia Business (2014-2019)
12.4.5 Boehringer Ingelheim Pharma Recent Development
12.5 Eli Lilly and Company
12.5.1 Eli Lilly and Company Company Details
12.5.2 Company Description and Business Overview
12.5.3 Benign Prostatic Hyperplasia Introduction
12.5.4 Eli Lilly and Company Revenue in Benign Prostatic Hyperplasia Business (2014-2019)
12.5.5 Eli Lilly and Company Recent Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Details
12.6.2 Company Description and Business Overview
12.6.3 Benign Prostatic Hyperplasia Introduction
12.6.4 GlaxoSmithKline Revenue in Benign Prostatic Hyperplasia Business (2014-2019)
12.6.5 GlaxoSmithKline Recent Development
12.7 Merck
12.7.1 Merck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Benign Prostatic Hyperplasia Introduction
12.7.4 Merck Revenue in Benign Prostatic Hyperplasia Business (2014-2019)
12.7.5 Merck Recent Development
12.8 Pfizer
12.8.1 Pfizer Company Details
12.8.2 Company Description and Business Overview
12.8.3 Benign Prostatic Hyperplasia Introduction
12.8.4 Pfizer Revenue in Benign Prostatic Hyperplasia Business (2014-2019)
12.8.5 Pfizer Recent Development
12.9 Sanofi
12.9.1 Sanofi Company Details
12.9.2 Company Description and Business Overview
12.9.3 Benign Prostatic Hyperplasia Introduction
12.9.4 Sanofi Revenue in Benign Prostatic Hyperplasia Business (2014-2019)
12.9.5 Sanofi Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Benign Prostatic Hyperplasia Key Market Segments
Table Key Players Benign Prostatic Hyperplasia Covered
Table Global Benign Prostatic Hyperplasia Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Benign Prostatic Hyperplasia Market Size Market Share by Type 2014-2025
Figure Drug Therapy Figures
Table Key Players of Drug Therapy
Figure Dialysis Figures
Table Key Players of Dialysis
Figure Other Figures
Table Key Players of Other
Table Global Benign Prostatic Hyperplasia Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Benign Prostatic Hyperplasia Report Years Considered
Table Global Benign Prostatic Hyperplasia Market Size 2014-2025 (Million US$)
Figure Global Benign Prostatic Hyperplasia Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Benign Prostatic Hyperplasia Market Size by Regions 2014-2025 (Million US$)
Table Global Benign Prostatic Hyperplasia Market Size by Regions 2014-2019 (Million US$)
Table Global Benign Prostatic Hyperplasia Market Share by Regions 2014-2019
Figure Global Benign Prostatic Hyperplasia Market Share by Regions 2014-2019
Figure Global Benign Prostatic Hyperplasia Market Share by Regions 2019
Table Market Top Trends
Table Global Benign Prostatic Hyperplasia Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Benign Prostatic Hyperplasia Market Share by Manufacturers (2014-2019)
Figure Global Benign Prostatic Hyperplasia Market Share by Manufacturers in 2018
Table Global Benign Prostatic Hyperplasia Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Benign Prostatic Hyperplasia Product/Solution/Service
Table Date of Enter into Benign Prostatic Hyperplasia Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Benign Prostatic Hyperplasia Market Size by Type (2014-2019) (Million US$)
Table Global Benign Prostatic Hyperplasia Market Size Share by Type (2014-2019)
Figure Global Benign Prostatic Hyperplasia Market Size Market Share by Type (2014-2019)
Table Global Benign Prostatic Hyperplasia Market Size by Application (2014-2019) (Million US$)
Table Global Benign Prostatic Hyperplasia Market Size Share by Application (2014-2019)
Figure Global Benign Prostatic Hyperplasia Market Size Market Share by Application (2014-2019)
Figure Global Benign Prostatic Hyperplasia Revenue Market Share by Application in 2018
Figure United States Benign Prostatic Hyperplasia Market Size 2014-2019 (Million US$)
Table United States Key Players Benign Prostatic Hyperplasia Revenue (2018-2019) (Million US$)
Table United States Key Players Benign Prostatic Hyperplasia Market Share (2018-2019)
Table United States Benign Prostatic Hyperplasia Market Size by Type (2014-2019) (Million US$)
Table United States Benign Prostatic Hyperplasia Market Share by Type (2014-2019)
Table United States Benign Prostatic Hyperplasia Market Size by Application (2014-2019) (Million US$)
Table United States Benign Prostatic Hyperplasia Market Share by Application (2014-2019)
Figure Europe Benign Prostatic Hyperplasia Market Size 2014-2019 (Million US$)
Table Europe Key Players Benign Prostatic Hyperplasia Revenue (2018-2019) (Million US$)
Table Europe Key Players Benign Prostatic Hyperplasia Market Share (2018-2019)
Table Europe Benign Prostatic Hyperplasia Market Size by Type (2014-2019) (Million US$)
Table Europe Benign Prostatic Hyperplasia Market Share by Type (2014-2019)
Table Europe Benign Prostatic Hyperplasia Market Size by Application (2014-2019) (Million US$)
Table Europe Benign Prostatic Hyperplasia Market Share by Application (2014-2019)
Figure China Benign Prostatic Hyperplasia Market Size 2014-2019 (Million US$)
Table China Key Players Benign Prostatic Hyperplasia Revenue (2018-2019) (Million US$)
Table China Key Players Benign Prostatic Hyperplasia Market Share (2018-2019)
Table China Benign Prostatic Hyperplasia Market Size by Type (2014-20189) (Million US$)
Table China Benign Prostatic Hyperplasia Market Share by Type (2014-2019)
Table China Benign Prostatic Hyperplasia Market Size by Application (2014-2019) (Million US$)
Table China Benign Prostatic Hyperplasia Market Share by Application (2014-2019)
Figure Japan Benign Prostatic Hyperplasia Market Size 2014-2019 (Million US$)
Table Japan Key Players Benign Prostatic Hyperplasia Revenue (2018-2019) (Million US$)
Table Japan Key Players Benign Prostatic Hyperplasia Market Share (2018-2019)
Table Japan Benign Prostatic Hyperplasia Market Size by Type (2014-2019) (Million US$)
Table Japan Benign Prostatic Hyperplasia Market Share by Type (2014-2019)
Table Japan Benign Prostatic Hyperplasia Market Size by Application (2014-2019) (Million US$)
Table Japan Benign Prostatic Hyperplasia Market Share by Application (2014-2019)
Figure Southeast Asia Benign Prostatic Hyperplasia Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Benign Prostatic Hyperplasia Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Benign Prostatic Hyperplasia Market Share (2018-2019)
Table Southeast Asia Benign Prostatic Hyperplasia Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Benign Prostatic Hyperplasia Market Share by Type (2014-2019)
Table Southeast Asia Benign Prostatic Hyperplasia Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Benign Prostatic Hyperplasia Market Share by Application (2014-2019)
Figure India Benign Prostatic Hyperplasia Market Size 2014-2019 (Million US$)
Table India Key Players Benign Prostatic Hyperplasia Revenue (2018-2019) (Million US$)
Table India Key Players Benign Prostatic Hyperplasia Market Share (2018-2019)
Table India Benign Prostatic Hyperplasia Market Size by Type (2014-2019) (Million US$)
Table India Benign Prostatic Hyperplasia Market Share by Type (2014-2019)
Table India Benign Prostatic Hyperplasia Market Size by Application (2014-2019) (Million US$)
Table India Benign Prostatic Hyperplasia Market Share by Application (2014-2019)
Figure Central & South America Benign Prostatic Hyperplasia Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Benign Prostatic Hyperplasia Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Benign Prostatic Hyperplasia Market Share (2018-2019)
Table Central & South America Benign Prostatic Hyperplasia Market Size by Type (2014-2019) (Million US$)
Table Central & South America Benign Prostatic Hyperplasia Market Share by Type (2014-2019)
Table Central & South America Benign Prostatic Hyperplasia Market Size by Application (2014-2019) (Million US$)
Table Central & South America Benign Prostatic Hyperplasia Market Share by Application (2014-2019)
Table Abbott Company Details
Table Abbott Revenue in Benign Prostatic Hyperplasia Business (2014-2019) (Million US$)
Figure Abbott Revenue Growth Rate in Benign Prostatic Hyperplasia Business (2014-2019)
Table Abbott Recent Development
Table Allergan Company Details
Table Allergan Revenue in Benign Prostatic Hyperplasia Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Benign Prostatic Hyperplasia Business (2014-2019)
Table Allergan Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Benign Prostatic Hyperplasia Business (2014-2019)(Million US$)
Figure Astellas Pharma Revenue Growth Rate in Benign Prostatic Hyperplasia Business (2014-2019)
Table Astellas Pharma Recent Development
Table Boehringer Ingelheim Pharma Company Details
Table Boehringer Ingelheim Pharma Revenue in Benign Prostatic Hyperplasia Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Pharma Revenue Growth Rate in Benign Prostatic Hyperplasia Business (2014-2019)
Table Boehringer Ingelheim Pharma Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Benign Prostatic Hyperplasia Business (2014-2019)(Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Benign Prostatic Hyperplasia Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Benign Prostatic Hyperplasia Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Benign Prostatic Hyperplasia Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Merck Company Details
Table Merck Revenue in Benign Prostatic Hyperplasia Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Benign Prostatic Hyperplasia Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Benign Prostatic Hyperplasia Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Benign Prostatic Hyperplasia Business (2014-2019)
Table Pfizer Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Benign Prostatic Hyperplasia Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Benign Prostatic Hyperplasia Business (2014-2019)
Table Sanofi Recent Development
Table Global Benign Prostatic Hyperplasia Market Size by Regions (Million US$) 2019-2025
Figure Global Benign Prostatic Hyperplasia Market Size Share by Regions (2019-2025)
Figure Global Benign Prostatic Hyperplasia Market Size Share by Regions in 2025
Figure United States Benign Prostatic Hyperplasia Market Size Forecast (2019-2025)(Million USD)
Figure Europe Benign Prostatic Hyperplasia Market Size Forecast (2019-2025)(Million USD)
Figure China Benign Prostatic Hyperplasia Market Size Forecast (2019-2025)(Million USD)
Figure Japan Benign Prostatic Hyperplasia Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Benign Prostatic Hyperplasia Market Size Forecast (2019-2025)(Million USD)
Figure India Benign Prostatic Hyperplasia Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Benign Prostatic Hyperplasia Market Size Forecast (2019-2025)(Million USD)
Table Global Benign Prostatic Hyperplasia Market Size by Product (2019-2025) (Million US$)
Figure Global Benign Prostatic Hyperplasia Market Size by Product (2019-2025)
Figure Global Benign Prostatic Hyperplasia Market Size by Product in 2025
Table Global Benign Prostatic Hyperplasia Market Size by Application (2019-2025) (Million US$)
Figure Global Benign Prostatic Hyperplasia Market Size by Application (2019-2025)
Figure Global Benign Prostatic Hyperplasia Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


★調査レポート[前立腺肥大症(BPH)の世界市場:市場規模・現状・予測(2019-2025)] (コード:QYR9051213)販売に関する免責事項を必ずご確認ください。
★調査レポート[前立腺肥大症(BPH)の世界市場:市場規模・現状・予測(2019-2025)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆